IO Biotech Announces Participation in Upcoming December Investor Conferences

Core Insights - IO Biotech is participating in two upcoming healthcare conferences, the Evercore Healthcare Conference and the Piper Sandler Healthcare Conference, where key executives will engage with investors [1][2]. Company Overview - IO Biotech is a clinical-stage biopharmaceutical company focused on developing immune-modulatory, off-the-shelf therapeutic cancer vaccines using its T-win® platform, which aims to activate T cells to target tumor cells and immune-suppressive cells in the tumor microenvironment [3]. - The company is advancing its lead cancer vaccine candidate, Cylembio®, through clinical trials, along with additional candidates in preclinical development [3]. - IO Biotech is headquartered in Copenhagen, Denmark, with a US office located in New York, New York [3].